Profile
Dr. Sherin Al-Safadi is a Vice President-Medical & Corporate Affairs at Radiopharm Theranostics Ltd. Dr. Al-Safadi was previously employed as a Vice President-Medical Affairs by POINT Biopharma Global, Inc. and a Director-Global Medical Affairs Oncology Strategy by Bayer Pharmaceuticals Corp.
She received her graduate degree from McGill University, an MBA from John Molson School of Business and a doctorate degree from Concordia University.
Sherin Al-Safadi active positions
| Companies | Position | Start |
|---|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Chief Tech/Sci/R&D Officer | 2023-07-23 |
Former positions of Sherin Al-Safadi
| Companies | Position | End |
|---|---|---|
Bayer Pharmaceuticals Corp. | Corporate Officer/Principal | - |
| POIT BIOP | Chief Tech/Sci/R&D Officer | - |
Education of Sherin Al-Safadi
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Bayer Pharmaceuticals Corp. | |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Concordia University
Concordia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
John Molson School of Business
John Molson School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
POINT Biopharma Global, Inc.
POINT Biopharma Global, Inc. BiotechnologyHealth Technology Develops radioligand therapies for the treatment of cancer | Health Technology |
Radiopharm Theranostics Ltd.
Radiopharm Theranostics Ltd. Medical/Nursing ServicesHealth Services Provides nuclear diagnostic services | Health Services |
- Stock Market
- Insiders
- Sherin Al-Safadi
















